38 datasets found

Alzheimer’s Drugs Market

transparencymarketresearch.com

csv, pdf

Updated Apr 1, 2024

Facebook

Twitter

Click to copy link

Link copied

Cite

Transparency Market Research (2024). Alzheimer’s Drugs Market [Dataset]. https://www.transparencymarketresearch.com/alzheimers-drugs-market.html

Explore at:

pdf, csvAvailable download formats

Dataset updated

Apr 1, 2024

Dataset authored and provided by

Transparency Market Research

License

https://www.transparencymarketresearch.com/privacy-policy.htmlhttps://www.transparencymarketresearch.com/privacy-policy.html

Time period covered

2024 - 2034

Area covered

Worldwide

Description

The global industry was valued at US$ 4.0 Bn in 2023
It is expected to advance at a CAGR of 10.0% from 2024 to 2034 and reach US$ 11.6 Bn by the end of 2034

Market Introduction

Attribute	Detail
Market Drivers	Rise in Awareness About Alzheimer’s Disease and Supportive Government Funding Advancements in Diagnosis and Treatment

Regional Outlook

Attribute	Detail
Leading Region	North America

Alzheimer's Drugs Market Snapshot

Attribute	Detail
Market Size in 2023	US$ 4.0 Bn
Market Forecast (Value) in 2034	US$ 11.6 Bn
Growth Rate (CAGR)	10.0%
Forecast Period	2024-2034
Historical Data Available for	2020-2022
Quantitative Units	US$ Bn for Value
Market Analysis	It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.
Competition Landscape	Market share analysis by company (2023) Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format	Electronic (PDF) + Excel
Market Segmentation	Drug Class Cholinergic Memantine Combined Drugs Others Distribution Channel Hospital Pharmacies Retail Pharmacies Online Sales
Regions Covered	North America Europe Asia Pacific Latin America Middle East & Africa
Countries Covered	U.S. Canada Germany U.K. France Italy Spain China India Japan Australia & New Zealand Brazil Mexico South Africa GCC
Companies Profiled	Allergan plc Novartis AG Eisai Co. Ltd. Johnson & Johnson Daiichi Sankyo Company Limited Ono Pharmaceutical Co. Ltd. H Lundbeck A/S Merz Holding GmbH & Co. KG
Customization Scope	Available Upon Request
Pricing	Available Upon Request

Global Alzheimer's Disease Market Research Report: By Type of Treatment...

wiseguyreports.com

Updated Oct 14, 2025

+ more versions

Facebook

Twitter

Click to copy link

Link copied

Cite

(2025). Global Alzheimer's Disease Market Research Report: By Type of Treatment (Pharmacological, Non-Pharmacological, Supportive Care), By Diagnosis Method (Clinical Assessment, Neuroimaging, Biomarkers), By Stage of Disease (Mild, Moderate, Severe), By End User (Hospitals, Homecare, Long-Term Care Facilities) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035 [Dataset]. https://www.wiseguyreports.com/reports/alzheimer-disease-market

Explore at:

Dataset updated

Oct 14, 2025

License

https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

Time period covered

Oct 25, 2025

Area covered

Global

Description

BASE YEAR	2024
HISTORICAL DATA	2019 - 2023
REGIONS COVERED	North America, Europe, APAC, South America, MEA
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
MARKET SIZE 2024	5.66(USD Billion)
MARKET SIZE 2025	6.21(USD Billion)
MARKET SIZE 2035	15.5(USD Billion)
SEGMENTS COVERED	Type of Treatment, Diagnosis Method, Stage of Disease, End User, Regional
COUNTRIES COVERED	US, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC, South Africa, Rest of MEA
KEY MARKET DYNAMICS	rising elderly population, increasing prevalence rates, robust research funding, advancements in diagnostic tools, growing demand for effective therapies
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	Amgen Inc, Biogen Inc, Sanofi SA, Merck & Co Inc, AstraZeneca PLC, Novartis AG, Takeda Pharmaceutical Company, Roche Holding AG, Johnson & Johnson, Eli Lilly and Company, AbbVie Inc, Pfizer Inc
MARKET FORECAST PERIOD	2025 - 2035
KEY MARKET OPPORTUNITIES	Innovative drug development, Early diagnosis technology, Telehealth services expansion, Personalized treatment approaches, Biopharmaceutical collaborations
COMPOUND ANNUAL GROWTH RATE (CAGR)	9.6% (2025 - 2035)

Global Alzheimer's Disease Diagnostic Market Research Report: By Diagnostic...

wiseguyreports.com

Updated Oct 14, 2025

+ more versions

Facebook

Twitter

Click to copy link

Link copied

Cite

(2025). Global Alzheimer's Disease Diagnostic Market Research Report: By Diagnostic Method (Cognitive Testing, Neuroimaging, Biomarker Testing, Genetic Testing), By End User (Hospitals, Diagnostic Laboratories, Research Institutes), By Product Type (Diagnostic Devices, Reagents, Software Solutions), By Age Group (65 Years and Older, 45 to 64 Years, Under 45 Years) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035 [Dataset]. https://www.wiseguyreports.com/reports/alzheimer-disease-diagnostic-market

Explore at:

Dataset updated

Oct 14, 2025

License

https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

Time period covered

Oct 25, 2025

Area covered

Global

Description

BASE YEAR	2024
HISTORICAL DATA	2019 - 2023
REGIONS COVERED	North America, Europe, APAC, South America, MEA
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
MARKET SIZE 2024	8.08(USD Billion)
MARKET SIZE 2025	8.61(USD Billion)
MARKET SIZE 2035	16.2(USD Billion)
SEGMENTS COVERED	Diagnostic Method, End User, Product Type, Age Group, Regional
COUNTRIES COVERED	US, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC, South Africa, Rest of MEA
KEY MARKET DYNAMICS	growing aging population, increasing prevalence rates, advancements in diagnostic technologies, rising healthcare expenditure, heightened awareness and education
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	Biogen Inc., Cerevel Therapeutics, Merck & Co., Inc., Novartis AG, Axovant Gene Therapies Ltd., Alzheon Inc., Pfizer Inc., Avid Radiopharmaceuticals, Roche Holding AG, BristolMyers Squibb Company, Cortech Solutions, AbbVie Inc., Quanterix Corporation, Johnson & Johnson, Eli Lilly and Company, Genentech Inc.
MARKET FORECAST PERIOD	2025 - 2035
KEY MARKET OPPORTUNITIES	Increased funding for research, Advancements in biomarker technology, Growing geriatric population, Rising awareness and education, Expanding telemedicine capabilities
COMPOUND ANNUAL GROWTH RATE (CAGR)	6.5% (2025 - 2035)

Global Early Diagnosis Kit for Alzheimer's Disease Market Research Report:...

wiseguyreports.com

Updated Oct 14, 2025

Facebook

Twitter

Click to copy link

Link copied

Cite

(2025). Global Early Diagnosis Kit for Alzheimer's Disease Market Research Report: By Test Type (Biomarker Tests, Genetic Tests, Neuropsychological Tests, Imaging Tests), By End User (Hospitals, Clinics, Home Care Settings, Research Institutions), By Distribution Channel (Direct Sales, Online Sales, Distributors, Retail Pharmacies) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035 [Dataset]. https://www.wiseguyreports.com/reports/early-diagnosi-kit-for-alzheimer-disease-market

Explore at:

Dataset updated

Oct 14, 2025

License

https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

Time period covered

Oct 25, 2025

Area covered

Global

Description

BASE YEAR	2024
HISTORICAL DATA	2019 - 2023
REGIONS COVERED	North America, Europe, APAC, South America, MEA
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
MARKET SIZE 2024	2.18(USD Billion)
MARKET SIZE 2025	2.35(USD Billion)
MARKET SIZE 2035	5.0(USD Billion)
SEGMENTS COVERED	Test Type, End User, Distribution Channel, Regional
COUNTRIES COVERED	US, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC, South Africa, Rest of MEA
KEY MARKET DYNAMICS	increasing aging population, rising prevalence of Alzheimer's, advancements in diagnostic technology, growing healthcare expenditure, awareness of early detection
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	Simoa, Genentech, Roche, Alzheimer's Diagnostics, Quidel Corporation, AbbVie, Merck, C2N Diagnostics, AstraZeneca, Neurotrack Technologies, Cogstate, Amgen, Eli Lilly, Johnson & Johnson, Biogen
MARKET FORECAST PERIOD	2025 - 2035
KEY MARKET OPPORTUNITIES	Increased aging population, Advancements in biomarker technology, Growing healthcare awareness, Government funding initiatives, Rise in home care settings
COMPOUND ANNUAL GROWTH RATE (CAGR)	7.8% (2025 - 2035)

Global Memory Care Market Research Report: By Type of Care (In-Home Care,...

wiseguyreports.com

Updated Oct 15, 2025

Facebook

Twitter

Click to copy link

Link copied

Cite

(2025). Global Memory Care Market Research Report: By Type of Care (In-Home Care, Assisted Living Facilities, Memory Care Facilities, Nursing Homes), By Diagnosis (Alzheimer's Disease, Vascular Dementia, Lewy Body Dementia, Frontotemporal Dementia, Mixed Dementia), By Service Type (Therapeutic Services, Respite Care, Adult Day Care, Counseling Services), By Age Group (65-74 years, 75-84 years, 85 years and older) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035 [Dataset]. https://www.wiseguyreports.com/reports/memory-care-market

Explore at:

Dataset updated

Oct 15, 2025

License

https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

Time period covered

Oct 25, 2025

Area covered

Global

Description

BASE YEAR	2024
HISTORICAL DATA	2019 - 2023
REGIONS COVERED	North America, Europe, APAC, South America, MEA
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
MARKET SIZE 2024	41.8(USD Billion)
MARKET SIZE 2025	44.0(USD Billion)
MARKET SIZE 2035	75.0(USD Billion)
SEGMENTS COVERED	Type of Care, Diagnosis, Service Type, Age Group, Regional
COUNTRIES COVERED	US, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC, South Africa, Rest of MEA
KEY MARKET DYNAMICS	Rising dementia prevalence, Increasing aging population, Growing healthcare expenditure, Enhanced caregiver support programs, Technological advancements in care solutions
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	Visiting Angels, Holiday Retirement, Senior Lifestyle Corporation, Genesis HealthCare, The Ensign Group, Kindred Healthcare, Sunrise Senior Living, Amedisys, LHC Group, Alzheimer's Association, Atria Senior Living, BAYADA Home Health Care, Five Star Senior Living, Cedarhurst, Spectrum Retirement Communities, Brookdale Senior Living
MARKET FORECAST PERIOD	2025 - 2035
KEY MARKET OPPORTUNITIES	Innovative caregiving technologies, Increased demand for specialized facilities, Growth in telehealth services, Rising awareness of dementia care, Expansion in geriatric population
COMPOUND ANNUAL GROWTH RATE (CAGR)	5.4% (2025 - 2035)

Global Artificial Intelligence AI in Alzheimer's Application Market Research...

wiseguyreports.com

Updated Sep 15, 2025

Facebook

Twitter

Click to copy link

Link copied

Cite

(2025). Global Artificial Intelligence AI in Alzheimer's Application Market Research Report: By Application (Early Diagnosis, Disease Monitoring, Treatment Personalization, Patient Management), By Technology (Machine Learning, Natural Language Processing, Computer Vision, Robotic Process Automation), By End User (Healthcare Providers, Research Institutions, Pharmaceutical Companies, Patients and Caregivers), By Solution Type (Software, Hardware, Services) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035 [Dataset]. https://www.wiseguyreports.com/reports/artificial-intelligence-ai-in-alzheimer-s-application-market

Explore at:

Dataset updated

Sep 15, 2025

License

https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

Time period covered

Sep 25, 2025

Area covered

Global

Description

BASE YEAR	2024
HISTORICAL DATA	2019 - 2023
REGIONS COVERED	North America, Europe, APAC, South America, MEA
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
MARKET SIZE 2024	2.0(USD Billion)
MARKET SIZE 2025	2.4(USD Billion)
MARKET SIZE 2035	15.0(USD Billion)
SEGMENTS COVERED	Application, Technology, End User, Solution Type, Regional
COUNTRIES COVERED	US, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC, South Africa, Rest of MEA
KEY MARKET DYNAMICS	Rising geriatric population, Increasing Alzheimer's prevalence, Advancements in AI technology, Growing healthcare investments, Enhanced diagnostic accuracy
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	IBM, Roche, Eli Lilly, Qure.ai, CureMetrix, NVIDIA, Dementia Discovery Fund, Mindstrong Health, Microsoft, Intel, Siemens, Amazon, Google, Biogen, BristolMyers Squibb, Neurotrack
MARKET FORECAST PERIOD	2025 - 2035
KEY MARKET OPPORTUNITIES	Early diagnosis technologies, Personalized treatment plans, AI-driven caregiver support, Drug development optimization, Predictive analytics for disease progression
COMPOUND ANNUAL GROWTH RATE (CAGR)	20.1% (2025 - 2035)

Global Cognitive Impairment Clinical Trial Market Research Report: By...

wiseguyreports.com

Updated Oct 14, 2025

Facebook

Twitter

Click to copy link

Link copied

Cite

(2025). Global Cognitive Impairment Clinical Trial Market Research Report: By Therapeutic Area (Alzheimer's Disease, Vascular Dementia, Mild Cognitive Impairment, Frontotemporal Dementia), By Phase of Clinical Trial (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional Study, Observational Study, Pilot Study, Longitudinal Study), By End User (Pharmaceutical Companies, Clinical Research Organizations, Academic Institutions) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035 [Dataset]. https://www.wiseguyreports.com/reports/cognitive-impairment-clinical-trial-market

Explore at:

Dataset updated

Oct 14, 2025

License

https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

Time period covered

Oct 25, 2025

Area covered

Global

Description

BASE YEAR	2024
HISTORICAL DATA	2019 - 2023
REGIONS COVERED	North America, Europe, APAC, South America, MEA
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
MARKET SIZE 2024	4.07(USD Billion)
MARKET SIZE 2025	4.33(USD Billion)
MARKET SIZE 2035	8.0(USD Billion)
SEGMENTS COVERED	Therapeutic Area, Phase of Clinical Trial, Study Design, End User, Regional
COUNTRIES COVERED	US, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC, South Africa, Rest of MEA
KEY MARKET DYNAMICS	Increasing elderly population, Rising prevalence of cognitive disorders, Advancements in clinical trial technologies, Regulatory support for innovative therapies, Growing investment in research initiatives
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	Takeda Pharmaceutical Company Limited, Biogen Inc., Merck & Co., Inc., AstraZeneca PLC, Novartis AG, Amgen Inc., Pfizer Inc., Roche Holding AG, Servier Laboratories, Sanofi S.A., AbbVie Inc., BristolMyers Squibb Company, Johnson & Johnson, Otsuka Pharmaceutical Co., Ltd., Eli Lilly and Company, Gilead Sciences, Inc.
MARKET FORECAST PERIOD	2025 - 2035
KEY MARKET OPPORTUNITIES	Rising aging population demand, Increased prevalence of cognitive disorders, Advancements in digital therapeutics, Government funding for research, Expansion of biomarker-based trials
COMPOUND ANNUAL GROWTH RATE (CAGR)	6.3% (2025 - 2035)

Global Memory Impairment Treatment Market Research Report: By Treatment Type...

wiseguyreports.com

Updated Sep 23, 2025

+ more versions

Facebook

Twitter

Click to copy link

Link copied

Cite

(2025). Global Memory Impairment Treatment Market Research Report: By Treatment Type (Medication, Therapy, Lifestyle Changes, Cognitive Rehabilitation), By Memory Impairment Type (Alzheimer's Disease, Dementia, Mild Cognitive Impairment, Vascular Cognitive Impairment), By Administration Route (Oral, Intravenous, Transdermal), By Age Group (Elderly, Adults, Children) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035 [Dataset]. https://www.wiseguyreports.com/reports/memory-impairment-treatment-market

Explore at:

Dataset updated

Sep 23, 2025

License

https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

Time period covered

Sep 25, 2025

Area covered

Global

Description

BASE YEAR	2024
HISTORICAL DATA	2019 - 2023
REGIONS COVERED	North America, Europe, APAC, South America, MEA
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
MARKET SIZE 2024	6.04(USD Billion)
MARKET SIZE 2025	6.56(USD Billion)
MARKET SIZE 2035	15.0(USD Billion)
SEGMENTS COVERED	Treatment Type, Memory Impairment Type, Administration Route, Age Group, Regional
COUNTRIES COVERED	US, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC, South Africa, Rest of MEA
KEY MARKET DYNAMICS	Aging population increase, Rising mental health awareness, Advancements in treatment options, Growing healthcare expenditure, Strong pipeline of drugs
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	AstraZeneca, Otsuka Pharmaceutical Co Ltd, Roche Holding AG, Takeda Pharmaceutical Company, Merck & Co Inc, Amgen Inc, Acadia Pharmaceuticals Inc, H. Lundbeck A/S, Sanofi, Biogen Inc, Novartis AG, AbbVie Inc, Pfizer Inc, Eli Lilly and Company, Johnson & Johnson
MARKET FORECAST PERIOD	2025 - 2035
KEY MARKET OPPORTUNITIES	Increased aging population demand, Rising prevalence of neurological disorders, Advancements in drug development, Growth in telehealth services, Expanding awareness of memory disorders
COMPOUND ANNUAL GROWTH RATE (CAGR)	8.6% (2025 - 2035)

Global Alzheimer's Agitation Treatment Market Research Report: By...

wiseguyreports.com

Updated Aug 22, 2025

+ more versions

Facebook

Twitter

Click to copy link

Link copied

Cite

(2025). Global Alzheimer's Agitation Treatment Market Research Report: By Therapeutic Class (Antidepressants, Antipsychotics, Mood Stabilizers, Anxiolytics), By Administration Route (Oral, Intravenous, Intramuscular, Transdermal), By Patient Type (Homecare Patients, Hospitalized Patients, Long-Term Care Facility Patients), By Dosage Form (Tablets, Injections, Liquid Solutions) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035 [Dataset]. https://www.wiseguyreports.com/reports/alzheimer-s-agitation-treatment-market

Explore at:

Dataset updated

Aug 22, 2025

License

https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

Time period covered

Aug 1, 2025

Area covered

Global

Description

BASE YEAR	2024
HISTORICAL DATA	2019 - 2023
REGIONS COVERED	North America, Europe, APAC, South America, MEA
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
MARKET SIZE 2024	2,200(USD Million)
MARKET SIZE 2025	2,400(USD Million)
MARKET SIZE 2035	5.0(USD Billion)
SEGMENTS COVERED	Therapeutic Class, Administration Route, Patient Type, Dosage Form, Regional
COUNTRIES COVERED	US, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC, South Africa, Rest of MEA
KEY MARKET DYNAMICS	Increasing aging population, Rising prevalence of Alzheimer's, Limited effective treatment options, Growing awareness and education, Advancements in therapeutic technologies
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	Novartis, Pfizer, Merck & Co., BristolMyers Squibb, Eli Lilly and Company, Roche, Teva Pharmaceutical Industries, Amgen, Johnson & Johnson, GSK, AbbVie, Sanofi, AstraZeneca
MARKET FORECAST PERIOD	2025 - 2035
KEY MARKET OPPORTUNITIES	Increasing prevalence of Alzheimer's cases, Growth of personalized medicine approaches, Expansion in telehealth treatment options, Advancements in neuropharmacological research, Rising demand for caregiver support services
COMPOUND ANNUAL GROWTH RATE (CAGR)	7.8% (2025 - 2035)

Global ApoE Gene Test Market Research Report: By Testing Method (Polymerase...

wiseguyreports.com

Updated Sep 5, 2025

+ more versions

Facebook

Twitter

Click to copy link

Link copied

Cite

(2025). Global ApoE Gene Test Market Research Report: By Testing Method (Polymerase Chain Reaction, Next-Generation Sequencing, Microarray Analysis, Sanger Sequencing), By Application (Cardiovascular Disease Risk Assessment, Alzheimer's Disease Risk Assessment, Personalized Treatment Plans, Genetic Counseling), By End User (Hospitals, Diagnostic Laboratories, Research Institutes, Home Healthcare), By Sample Type (Blood, Saliva, Tissue, Urine) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035 [Dataset]. https://www.wiseguyreports.com/reports/apo-e-gene-test-market

Explore at:

Dataset updated

Sep 5, 2025

License

https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

Time period covered

Sep 25, 2025

Area covered

Global

Description

BASE YEAR	2024
HISTORICAL DATA	2019 - 2023
REGIONS COVERED	North America, Europe, APAC, South America, MEA
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
MARKET SIZE 2024	935.9(USD Million)
MARKET SIZE 2025	1023.0(USD Million)
MARKET SIZE 2035	2500.0(USD Million)
SEGMENTS COVERED	Testing Method, Application, End User, Sample Type, Regional
COUNTRIES COVERED	US, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC, South Africa, Rest of MEA
KEY MARKET DYNAMICS	Growing Alzheimer's prevalence, Increasing genetic testing awareness, Advancements in DNA sequencing technology, Rising demand for personalized medicine, Regulatory support for gene testing
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	Sema4, Agena Bioscience, PathAI, 23andMe, Color Genomics, Ambry Genetics, Invitae, Fulgent Genetics, GeneVault, Myriad Genetics, Natera, GeneDx, Quest Diagnostics, Guardant Health, Haplogen
MARKET FORECAST PERIOD	2025 - 2035
KEY MARKET OPPORTUNITIES	Increasing demand for personalized medicine, Growing prevalence of Alzheimer's disease, Advancements in genetic testing technologies, Rising awareness of genetic risks, Expansion in direct-to-consumer testing
COMPOUND ANNUAL GROWTH RATE (CAGR)	9.3% (2025 - 2035)

Global Neurological Biomarker Market Research Report: By Application...

wiseguyreports.com

Updated Sep 15, 2025

+ more versions

Facebook

Twitter

Click to copy link

Link copied

Cite

(2025). Global Neurological Biomarker Market Research Report: By Application (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Stroke), By Type (Biochemical Markers, Genetic Markers, Imaging Biomarkers, Neurophysiological Biomarkers), By End Use (Diagnostic Centers, Hospitals, Research Institutions, Pharmaceutical Companies), By Testing Method (Blood Tests, Lumbar Puncture, Neuroimaging, Electrophysiological Tests) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035 [Dataset]. https://www.wiseguyreports.com/reports/neurological-biomarker-market

Explore at:

Dataset updated

Sep 15, 2025

License

https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

Time period covered

Sep 25, 2025

Area covered

Global

Description

BASE YEAR	2024
HISTORICAL DATA	2019 - 2023
REGIONS COVERED	North America, Europe, APAC, South America, MEA
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
MARKET SIZE 2024	5.84(USD Billion)
MARKET SIZE 2025	6.23(USD Billion)
MARKET SIZE 2035	12.0(USD Billion)
SEGMENTS COVERED	Application, Type, End Use, Testing Method, Regional
COUNTRIES COVERED	US, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC, South Africa, Rest of MEA
KEY MARKET DYNAMICS	Rising prevalence of neurological disorders, Increasing demand for early diagnosis, Advancements in biomarker technologies, Growing investment in research and development, Expanding applications in drug discovery
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	Erytech Pharma, Axovant Gene Therapies, Quanterix, Johnson & Johnson, Amgen, Roche, AbbVie, Merck & Co, Pfizer, Genentech, Alzheimer's Drug Discovery Foundation, Biogen, Novartis, Scripps Research, C2N Diagnostics, Eli Lilly
MARKET FORECAST PERIOD	2025 - 2035
KEY MARKET OPPORTUNITIES	Rising demand for early diagnosis, Increasing prevalence of neurological disorders, Advancements in biomarker discovery technology, Growing investment in personalized medicine, Supportive regulatory frameworks for biomarker development
COMPOUND ANNUAL GROWTH RATE (CAGR)	6.8% (2025 - 2035)

Global Memantine HCl Market Research Report: By Application (Alzheimer's...

wiseguyreports.com

Updated Sep 9, 2025

Facebook

Twitter

Click to copy link

Link copied

Cite

(2025). Global Memantine HCl Market Research Report: By Application (Alzheimer's Disease Treatment, Vascular Dementia Treatment, Other Neurodegenerative Disorders), By Formulation (Oral Tablets, Oral Solution, Extended-Release Capsules), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By End User (Hospitals, Clinics, Home Care Settings) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035 [Dataset]. https://www.wiseguyreports.com/reports/memantine-hcl-market

Explore at:

Dataset updated

Sep 9, 2025

License

https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

Time period covered

Sep 25, 2025

Area covered

Global

Description

BASE YEAR	2024
HISTORICAL DATA	2019 - 2023
REGIONS COVERED	North America, Europe, APAC, South America, MEA
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
MARKET SIZE 2024	1634.6(USD Million)
MARKET SIZE 2025	1698.3(USD Million)
MARKET SIZE 2035	2500.0(USD Million)
SEGMENTS COVERED	Application, Formulation, Distribution Channel, End User, Regional
COUNTRIES COVERED	US, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC, South Africa, Rest of MEA
KEY MARKET DYNAMICS	Rising Alzheimer's cases, Expanding geriatric population, Increased global healthcare expenditure, Growing awareness of dementia treatments, Competitive pricing strategies
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	Zydus Cadila, Apex Pharma, Merz Pharmaceuticals, Sandoz, Hikma Pharmaceuticals, Lundbeck, Alvogen, Hetero Drugs, Otsuka Pharmaceutical, Fresenius Kabi, Sun Pharmaceutical Industries, Mallinckrodt Pharmaceuticals, Mylan, Granules India, Teva Pharmaceutical Industries
MARKET FORECAST PERIOD	2025 - 2035
KEY MARKET OPPORTUNITIES	Rising Alzheimer’s disease prevalence, Increasing geriatric population, Expanding pipeline of drug formulations, Growing awareness and diagnosis, Emerging markets expansion
COMPOUND ANNUAL GROWTH RATE (CAGR)	3.9% (2025 - 2035)

Global Immunoassay for Neurological Biomarker Market Research Report: By...

wiseguyreports.com

Updated Oct 14, 2025

Facebook

Twitter

Click to copy link

Link copied

Cite

(2025). Global Immunoassay for Neurological Biomarker Market Research Report: By Application (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Epilepsy), By Technology (Enzyme-Linked Immunosorbent Assay, Lateral Flow Assay, Radioimmunoassay, Fluorescent Immunoassay), By End User (Hospitals, Diagnostic Laboratories, Research Institutions, Pharmaceutical Companies), By Region (North America, Europe, Asia Pacific, Latin America) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035 [Dataset]. https://www.wiseguyreports.com/reports/immunoassay-for-neurological-biomarker-market

Explore at:

Dataset updated

Oct 14, 2025

License

https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

Time period covered

Oct 25, 2025

Area covered

Global

Description

BASE YEAR	2024
HISTORICAL DATA	2019 - 2023
REGIONS COVERED	North America, Europe, APAC, South America, MEA
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
MARKET SIZE 2024	3.82(USD Billion)
MARKET SIZE 2025	4.06(USD Billion)
MARKET SIZE 2035	7.5(USD Billion)
SEGMENTS COVERED	Application, Technology, End User, Region, Regional
COUNTRIES COVERED	US, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC, South Africa, Rest of MEA
KEY MARKET DYNAMICS	Rising prevalence of neurological disorders, Advancements in biomarker discovery, Increasing demand for early diagnosis, Growth of personalized medicine, Technological innovations in immunoassays
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	Siemens Healthineers, BioRad Laboratories, BD, PerkinElmer, Merck KGaA, Abbott Laboratories, F. HoffmannLa Roche AG, Ortho Clinical Diagnostics, Roche Diagnostics, Waters Corporation, Thermo Fisher Scientific, Quidel Corporation
MARKET FORECAST PERIOD	2025 - 2035
KEY MARKET OPPORTUNITIES	Increasing prevalence of neurological disorders, Advancements in assay technology, Growing demand for personalized medicine, Rising investment in biomarker research, Expansion of point-of-care testing
COMPOUND ANNUAL GROWTH RATE (CAGR)	6.4% (2025 - 2035)

Global Memantine Hydrochloride Extended Release Capsule Market Research...

wiseguyreports.com

Updated Aug 4, 2025

Facebook

Twitter

Click to copy link

Link copied

Cite

(2025). Global Memantine Hydrochloride Extended Release Capsule Market Research Report: By Application (Alzheimer's Disease, Vascular Dementia, Parkinson's Disease), By Dosage Form (Capsule, Tablet, Liquid), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End Use (Hospital, Homecare, Specialized Clinics) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035 [Dataset]. https://www.wiseguyreports.com/reports/memantine-hydrochloride-extended-release-capsule-market

Explore at:

Dataset updated

Aug 4, 2025

License

https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

Time period covered

Aug 1, 2025

Area covered

Global

Description

BASE YEAR	2024
HISTORICAL DATA	2019 - 2023
REGIONS COVERED	North America, Europe, APAC, South America, MEA
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
MARKET SIZE 2024	800(USD Million)
MARKET SIZE 2025	800(USD Million)
MARKET SIZE 2035	1,500(USD Million)
SEGMENTS COVERED	Application, Dosage Form, Distribution Channel, End Use, Regional
COUNTRIES COVERED	US, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC, South Africa, Rest of MEA
KEY MARKET DYNAMICS	Increasing Alzheimer’s disease prevalence, Growing demand for extended-release formulations, Regulatory approval challenges, Patent expirations and generic competition, Rising healthcare expenditure
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	Teva Pharmaceutical Industries, BristolMyers Squibb, Mylan, Sandoz, Zydus Cadila, Fresenius Kabi, Aurobindo Pharma, Alkermes, Emcure Pharmaceuticals, Sun Pharmaceutical Industries, Amgen, Cipla, H. Lundbeck A/S, Lundbeck, AstraZeneca
MARKET FORECAST PERIOD	2025 - 2035
KEY MARKET OPPORTUNITIES	Increasing Alzheimer's disease prevalence, Rising geriatric population, Expanding generic drug market, Innovative delivery technologies, Collaboration with healthcare providers
COMPOUND ANNUAL GROWTH RATE (CAGR)	5.9% (2025 - 2035)

Global Neurological Disorder Drug Market Research Report: By Drug Type...

wiseguyreports.com

Updated Oct 14, 2025

+ more versions

Facebook

Twitter

Click to copy link

Link copied

Cite

(2025). Global Neurological Disorder Drug Market Research Report: By Drug Type (Antidepressants, Antipsychotics, Stimulants, Antiseizure, Anxiolytics), By Application (Epilepsy, Depression, Parkinson's Disease, Multiple Sclerosis, Alzheimer's Disease), By Route of Administration (Oral, Injectable, Transdermal, Intranasal, Topical), By Therapeutic Area (Mood Disorders, Anxiety Disorders, Psychotic Disorders, Neurodegenerative Diseases, Seizure Disorders) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035 [Dataset]. https://www.wiseguyreports.com/reports/neurological-disorder-drug-market

Explore at:

Dataset updated

Oct 14, 2025

License

https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

Time period covered

Oct 25, 2025

Area covered

Global

Description

BASE YEAR	2024
HISTORICAL DATA	2019 - 2023
REGIONS COVERED	North America, Europe, APAC, South America, MEA
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
MARKET SIZE 2024	101.4(USD Billion)
MARKET SIZE 2025	105.1(USD Billion)
MARKET SIZE 2035	150.0(USD Billion)
SEGMENTS COVERED	Drug Type, Application, Route of Administration, Therapeutic Area, Regional
COUNTRIES COVERED	US, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC, South Africa, Rest of MEA
KEY MARKET DYNAMICS	Aging population increase, Rising prevalence rates, Advancements in drug development, Growing awareness and diagnosis
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	Otsuka Pharmaceutical, Sanofi, Novartis, Roche, Mylan, AbbVie, Gilead Sciences, Pfizer, Merck & Co., BristolMyers Squibb, Amgen, AstraZeneca, Teva Pharmaceutical Industries, Eli Lilly, Johnson & Johnson, Biogen
MARKET FORECAST PERIOD	2025 - 2035
KEY MARKET OPPORTUNITIES	Aging population growth, Increased prevalence of neurological disorders, Advancements in drug development technologies, Rising investment in R&D, Expanding telemedicine solutions for treatment
COMPOUND ANNUAL GROWTH RATE (CAGR)	3.6% (2025 - 2035)

Global Dementia Movement Disorder Treatment Market Research Report: By...

wiseguyreports.com

Updated Sep 24, 2025

+ more versions

Facebook

Twitter

Click to copy link

Link copied

Cite

(2025). Global Dementia Movement Disorder Treatment Market Research Report: By Treatment Type (Medications, Therapies, Surgical Procedures), By Condition Type (Alzheimer's Disease, Parkinson's Disease, Lewy Body Dementia, Vascular Dementia), By Care Setting (Home Care, Hospitals, Specialized Clinics, Nursing Homes), By Patient Age Group (Young Adults, Middle-Aged Adults, Elderly) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035 [Dataset]. https://www.wiseguyreports.com/reports/dementia-movement-disorder-treatment-market

Explore at:

Dataset updated

Sep 24, 2025

License

https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

Time period covered

Sep 25, 2025

Area covered

Global

Description

BASE YEAR	2024
HISTORICAL DATA	2019 - 2023
REGIONS COVERED	North America, Europe, APAC, South America, MEA
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
MARKET SIZE 2024	6.97(USD Billion)
MARKET SIZE 2025	7.48(USD Billion)
MARKET SIZE 2035	15.2(USD Billion)
SEGMENTS COVERED	Treatment Type, Condition Type, Care Setting, Patient Age Group, Regional
COUNTRIES COVERED	US, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC, South Africa, Rest of MEA
KEY MARKET DYNAMICS	Aging population increase, Rising prevalence rates, Advancements in treatment options, Growing healthcare expenditures, Emerging drug developments
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	AstraZeneca, Takeda, Otsuka, AbbVie, Roche, Lundbeck, Merck, Amgen, Sanofi, Pfizer, Eli Lilly, Eisai, Novartis, Johnson & Johnson, Biogen
MARKET FORECAST PERIOD	2025 - 2035
KEY MARKET OPPORTUNITIES	Innovative drug development, Telehealth integration, Biomarker research advancements, Personalized treatment approaches, Increased caregiver support services
COMPOUND ANNUAL GROWTH RATE (CAGR)	7.3% (2025 - 2035)

Global Donepezil Drug Market Research Report: By Application (Alzheimer's...

wiseguyreports.com

Updated Aug 24, 2025

+ more versions

Facebook

Twitter

Click to copy link

Link copied

Cite

(2025). Global Donepezil Drug Market Research Report: By Application (Alzheimer's Disease, Dementia, Cognitive Disorders), By Formulation (Tablet, Oral Solution, Liquid), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By End Use (Hospitals, Home Healthcare, Specialized Clinics) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035 [Dataset]. https://www.wiseguyreports.com/reports/donepezil-drug-market

Explore at:

Dataset updated

Aug 24, 2025

License

https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

Time period covered

Aug 1, 2025

Area covered

Global

Description

BASE YEAR	2024
HISTORICAL DATA	2019 - 2023
REGIONS COVERED	North America, Europe, APAC, South America, MEA
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
MARKET SIZE 2024	1,800(USD Million)
MARKET SIZE 2025	1,900(USD Million)
MARKET SIZE 2035	2,500(USD Million)
SEGMENTS COVERED	Application, Formulation, Distribution Channel, End Use, Regional
COUNTRIES COVERED	US, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC, South Africa, Rest of MEA
KEY MARKET DYNAMICS	Increasing Alzheimer's prevalence, Expanding geriatric population, Growing demand for symptomatic treatment, Rising healthcare expenditure, Generic competition intensifying
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	Novartis, Pfizer, BristolMyers Squibb, Roche, Teva Pharmaceuticals, Mylan, Takeda Pharmaceutical, Eisai, Helsinn Healthcare, Amgen, Johnson & Johnson, GSK, AbbVie, Sanofi, Boehringer Ingelheim
MARKET FORECAST PERIOD	2025 - 2035
KEY MARKET OPPORTUNITIES	Increasing elderly population, Rising Alzheimer's disease prevalence, Expanding generic drug availability, Innovative delivery methods, Growing awareness and diagnosis
COMPOUND ANNUAL GROWTH RATE (CAGR)	2.8% (2025 - 2035)

Global Rivastigmine Tartrate Market Research Report: By Application...

wiseguyreports.com

Updated Aug 6, 2025

+ more versions

Facebook

Twitter

Click to copy link

Link copied

Cite

(2025). Global Rivastigmine Tartrate Market Research Report: By Application (Alzheimer's Disease Treatment, Parkinson's Disease Treatment, Cognitive Enhancer), By Formulation (Capsules, Transdermal Patches, Oral Solution), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End User (Hospitals, Clinics, Home Care) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035 [Dataset]. https://www.wiseguyreports.com/reports/rivastigmine-tartrate-market

Explore at:

Dataset updated

Aug 6, 2025

License

https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

Time period covered

Aug 1, 2025

Area covered

Global

Description

BASE YEAR	2024
HISTORICAL DATA	2019 - 2023
REGIONS COVERED	North America, Europe, APAC, South America, MEA
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
MARKET SIZE 2024	700(USD Million)
MARKET SIZE 2025	700(USD Million)
MARKET SIZE 2035	1,200(USD Million)
SEGMENTS COVERED	Application, Formulation, Distribution Channel, End User, Regional
COUNTRIES COVERED	US, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC, South Africa, Rest of MEA
KEY MARKET DYNAMICS	increasing prevalence of dementia, growing geriatric population, rising awareness and diagnosis, advancements in drug formulation, competitive pricing strategies
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	Novartis, Piramal Pharma Solutions, Sihuan Pharmaceutical, Teva Pharmaceutical Industries, Mylan, Sandoz, Zydus Cadila, Fresenius Kabi, Aurobindo Pharma, Lupin Pharmaceuticals, Alkermes, Intas Pharmaceuticals, Hikma Pharmaceuticals, Hunan ErKang Pharmaceutical, Sun Pharmaceutical Industries, Cipla
MARKET FORECAST PERIOD	2025 - 2035
KEY MARKET OPPORTUNITIES	Increasing dementia prevalence, Rising geriatric population, Expanding healthcare infrastructure, Growing awareness of Alzheimer's treatments, Enhanced drug delivery systems
COMPOUND ANNUAL GROWTH RATE (CAGR)	5.6% (2025 - 2035)

Global Cognitive Screening Tools Market Research Report: By Type (Digital...

wiseguyreports.com

Updated Aug 19, 2025

+ more versions

Facebook

Twitter

Click to copy link

Link copied

Cite

(2025). Global Cognitive Screening Tools Market Research Report: By Type (Digital Tools, Paper-based Tools, Mobile Applications, Telehealth Tools), By Application (Alzheimer's Disease Screening, Dementia Assessment, Cognitive Decline Monitoring, Mental Health Assessment), By End Use (Healthcare Providers, Research Institutions, Homecare Settings, Educational Institutions), By Patient Demographics (Geriatric Population, Adults with Cognitive Disorders, General Population, Children and Adolescents) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035 [Dataset]. https://www.wiseguyreports.com/reports/cognitive-screening-tools-market

Explore at:

Dataset updated

Aug 19, 2025

License

https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

Time period covered

Aug 25, 2025

Area covered

Global

Description

BASE YEAR	2024
HISTORICAL DATA	2019 - 2023
REGIONS COVERED	North America, Europe, APAC, South America, MEA
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
MARKET SIZE 2024	2128.7(USD Million)
MARKET SIZE 2025	2226.6(USD Million)
MARKET SIZE 2035	3500.0(USD Million)
SEGMENTS COVERED	Type, Application, End Use, Patient Demographics, Regional
COUNTRIES COVERED	US, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC, South Africa, Rest of MEA
KEY MARKET DYNAMICS	Aging population prevalence, Rising mental health awareness, Advancements in technology, Increased healthcare expenditure, Government initiatives and funding
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	Nexstim, Eisai, Lumos Labs, MindMate, Dem Dx, Cambridge Cognition, Unity Biotechnology, Idorsia Pharmaceuticals, CogniFit, Neurotrack Technologies, BrainTest, Alzheimer's Association, AARP, Pear Therapeutics, Cogstate, Dementia Care Specialists
MARKET FORECAST PERIOD	2025 - 2035
KEY MARKET OPPORTUNITIES	Aging population increase, Technological advancements in AI, Rising prevalence of dementia, Growing demand for early diagnosis, Expanding telehealth services
COMPOUND ANNUAL GROWTH RATE (CAGR)	4.6% (2025 - 2035)

Global Brain Disease Modality and Software Market Research Report: By...

wiseguyreports.com

Updated Sep 15, 2025

+ more versions

Facebook

Twitter

Click to copy link

Link copied

Cite

(2025). Global Brain Disease Modality and Software Market Research Report: By Modality Type (Imaging Modality, Therapeutic Modality, Software Solutions), By Application (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Traumatic Brain Injury), By End User (Hospitals, Clinics, Research Institutions, Home Care Settings), By Deployment Mode (On-Premises, Cloud-Based, Hybrid) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035 [Dataset]. https://www.wiseguyreports.com/reports/brain-disease-modality-and-software-market

Explore at:

Dataset updated

Sep 15, 2025

License

https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

Time period covered

Sep 25, 2025

Area covered

Global

Description

BASE YEAR	2024
HISTORICAL DATA	2019 - 2023
REGIONS COVERED	North America, Europe, APAC, South America, MEA
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
MARKET SIZE 2024	2.51(USD Billion)
MARKET SIZE 2025	2.69(USD Billion)
MARKET SIZE 2035	5.2(USD Billion)
SEGMENTS COVERED	Modality Type, Application, End User, Deployment Mode, Regional
COUNTRIES COVERED	US, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC, South Africa, Rest of MEA
KEY MARKET DYNAMICS	Rising prevalence of brain diseases, Increasing demand for advanced diagnostics, Growth of telemedicine solutions, Innovation in medical imaging technologies, Government funding for research initiatives
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	Siemens Healthineers, IBM, Fujifilm Holdings, NVIDIA, Philips Healthcare, Roche Diagnostics, Medtronic, Amgen, Cerner Corporation, NeuroPace, Elekta, Unity Biotechnology, Biogen, GE Healthcare, BrainView
MARKET FORECAST PERIOD	2025 - 2035
KEY MARKET OPPORTUNITIES	Telemedicine integration for remote care, AI-driven diagnostics tools, Enhanced imaging software solutions, Personalized treatment planning technologies, Improved patient data analytics platforms
COMPOUND ANNUAL GROWTH RATE (CAGR)	6.9% (2025 - 2035)

Facebook

Twitter

Click to copy link

Link copied

Cite

Transparency Market Research (2024). Alzheimer’s Drugs Market [Dataset]. https://www.transparencymarketresearch.com/alzheimers-drugs-market.html

Alzheimer’s Drugs Market

Explore at:

4 scholarly articles cite this dataset (View in Google Scholar)

pdf, csvAvailable download formats

Dataset updated

Apr 1, 2024

Dataset authored and provided by

Transparency Market Research

License

https://www.transparencymarketresearch.com/privacy-policy.htmlhttps://www.transparencymarketresearch.com/privacy-policy.html

Time period covered

2024 - 2034

Area covered

Worldwide

Description

The global industry was valued at US$ 4.0 Bn in 2023
It is expected to advance at a CAGR of 10.0% from 2024 to 2034 and reach US$ 11.6 Bn by the end of 2034

Market Introduction

Attribute	Detail
Market Drivers	Rise in Awareness About Alzheimer’s Disease and Supportive Government Funding Advancements in Diagnosis and Treatment

Regional Outlook

Attribute	Detail
Leading Region	North America

Alzheimer's Drugs Market Snapshot

Attribute	Detail
Market Size in 2023	US$ 4.0 Bn
Market Forecast (Value) in 2034	US$ 11.6 Bn
Growth Rate (CAGR)	10.0%
Forecast Period	2024-2034
Historical Data Available for	2020-2022
Quantitative Units	US$ Bn for Value
Market Analysis	It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.
Competition Landscape	Market share analysis by company (2023) Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format	Electronic (PDF) + Excel
Market Segmentation	Drug Class Cholinergic Memantine Combined Drugs Others Distribution Channel Hospital Pharmacies Retail Pharmacies Online Sales
Regions Covered	North America Europe Asia Pacific Latin America Middle East & Africa
Countries Covered	U.S. Canada Germany U.K. France Italy Spain China India Japan Australia & New Zealand Brazil Mexico South Africa GCC
Companies Profiled	Allergan plc Novartis AG Eisai Co. Ltd. Johnson & Johnson Daiichi Sankyo Company Limited Ono Pharmaceutical Co. Ltd. H Lundbeck A/S Merz Holding GmbH & Co. KG
Customization Scope	Available Upon Request
Pricing	Available Upon Request

Clear search

Close search

Google apps

Main menu